lipoxin a4 has been researched along with Lymphangiomyomatosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auricchio, N; Blenis, J; Csibi, A; Gu, X; Guo, Y; Henske, EP; Israel, E; Kazani, S; Kwiatkowski, D; Lee, PS; Levy, BD; Li, C; Li, J; Morrison, T; Parkhitko, A; Planaguma, A; Priolo, C; Sun, Y; Wu, CL; Xu, KF; Yu, JJ; Zhang, E | 1 |
1 other study(ies) available for lipoxin a4 and Lymphangiomyomatosis
Article | Year |
---|---|
Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells.
Topics: Analysis of Variance; Animals; Aspirin; Breath Tests; Carcinogenesis; Carrier Proteins; Cell Proliferation; Cyclooxygenase 2; Estradiol; Female; Gene Expression Regulation, Enzymologic; Gene Knockdown Techniques; Humans; Immunoblotting; Immunohistochemistry; Lipoxins; Lymphangioleiomyomatosis; Mechanistic Target of Rapamycin Complex 2; Metabolomics; Mice; Mice, SCID; Microscopy, Confocal; Multiprotein Complexes; Naphthyridines; Prostaglandins; Rapamycin-Insensitive Companion of mTOR Protein; Real-Time Polymerase Chain Reaction; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins | 2014 |